MedTrace Logo

Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts

NCT05712551 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2024-06-17

No results posted yet for this study

Summary

It has been suggested that pathologists' diagnostic accuracy and confidence could be improved if they gained access to additional clinical information and in-vivo clinical and dermoscopic images of melanocytic tumors. This study examines the effect of digital training for pathologists in interpreting dermoscopic and clinical skin tumor images. The primary outcome of the upcoming DAHT RCT (Dermoscopy Augmented Histology Trial, a randomized controlled trial) is the diagnostic value (accuracy, sensitivity, and specificity) for the intervention and control group. For this purpose, we need an expert agreeable MPATH-Dx classification and diagnosis for all DAHT cases. The DAHT consensus trial strives to establish this gold standard through a four-phased Delphi-like process.

Aim: To establish an expert agreeable MPTAH-Dx classification and diagnosis for all DAHT cases.

Data collection of DAHT cases: Department of plastic surgery, Herlev hospital, year 2020-2021

DAHT platform: Made in 2021-2023 by Melatech

Consensus agreement: Four dermatopathologists assess all DAHT cases, year 2023-2024

Conditions

  • Melanoma (Skin)
  • Pigmented Lesions

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Lisbet Rosenkrantz Hôlmich, MD. prof. · Herlev University Hospital, Denmark

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-24
Primary Completion
2024-12-29
Completion
2025-12-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05712551 on ClinicalTrials.gov